136 related articles for article (PubMed ID: 10414461)
1. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy.
Galanis E; Frytak S; Rowland KM; Sloan JA; Lennon VA
Cancer Immunol Immunother; 1999; 48(2-3):85-90. PubMed ID: 10414461
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
Kiers L; Altermatt HJ; Lennon VA
Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
[TBL] [Abstract][Full Text] [Related]
3. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies of IgM type against small cell lung carcinoma and 29 kD neuronal antigen of rat in a patient with paraneoplastic sensory neuropathy].
Azuma A; Kurimoto F; Ishida K; Morikawa T; Kawamoto M; Kudoh S
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):241-6. PubMed ID: 7553060
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.
Anderson NE; Rosenblum MK; Graus F; Wiley RG; Posner JB
Neurology; 1988 Sep; 38(9):1391-8. PubMed ID: 2842702
[TBL] [Abstract][Full Text] [Related]
6. Initial screening for neuronal autoantibodies and their putative impact on survival in patients with small-cell lung cancer.
Mikkelsen AW; Nilsson AC; Tenstad HB; Lillevang ST; Asgari N
Thorac Cancer; 2024 Jun; 15(17):1350-1356. PubMed ID: 38703039
[TBL] [Abstract][Full Text] [Related]
7. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
[TBL] [Abstract][Full Text] [Related]
8. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in neurological paraneoplastic diseases.
Lövblad KO; Boucraut J; Lehmann HP; Stahel R; Regli F; Steck AJ
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(3):3-7. PubMed ID: 7533934
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
11. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis.
Dalmau J; Furneaux HM; Gralla RJ; Kris MG; Posner JB
Ann Neurol; 1990 May; 27(5):544-52. PubMed ID: 2163235
[TBL] [Abstract][Full Text] [Related]
12. Antineuronal antibodies in small cell lung carcinoma--a significance for paraneoplastic syndromes?
Grisold W; Drlicek M; Popp W; Jellinger K
Acta Neuropathol; 1987; 75(2):199-202. PubMed ID: 2829498
[TBL] [Abstract][Full Text] [Related]
13. Anti-neuronal antibodies in paraneoplastic neurological disorders with small-cell lung carcinoma.
Moll JW; Henzen-Logmans SC; Vecht CJ
Clin Neurol Neurosurg; 1990; 92(3):223-8. PubMed ID: 2171829
[TBL] [Abstract][Full Text] [Related]
14. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
15. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
Lucchinetti CF; Kimmel DW; Lennon VA
Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
[TBL] [Abstract][Full Text] [Related]
17. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
18. Sensory neuronopathy and small cell lung cancer: antineuronal antibody reacting with neuroblastoma cells.
Lövblad KO; Boucraut J; Bourdenet S; Burger D; Bernard D; Regli F; Steck AJ
J Neurol; 1993 Jun; 240(6):327-32. PubMed ID: 8393093
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival.
Winter SF; Sekido Y; Minna JD; McIntire D; Johnson BE; Gazdar AF; Carbone DP
J Natl Cancer Inst; 1993 Dec; 85(24):2012-8. PubMed ID: 8246287
[TBL] [Abstract][Full Text] [Related]
20. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
